CVS vs PCVX · P/E 16, rev $402.07B vs $6.84B cap
CVS Health Corp (CVS) versus Vaxcyte Inc (PCVX) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Vaxcyte Inc (PCVX) is a biotechnology company listed on US.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
PCVX does not have a complete income-statement cache yet.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. PCVX currently screens at market cap $6.84B.
Not investment advice. Open the CVS and PCVX stock pages for the full models.
Not investment advice.